Glonoinum
Pellet · Oral
Active ingredient
6X and higher
Purpose
USES USES: Temporary Relief - Congestive Headache* * Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
Condition listed above or as directed by the physician
Warnings
This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use.
Do not use
Do not use if capseal is broken or missing. Close the cap tightly after use.
Stop use and ask a doctor
If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional
Pregnancy or breast-feeding
As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product
Keep out of reach of children
Keep this and all medication out of reach of children
Directions
Adults: Mix 4-6 drops in 1/2 cup of water, take orally three times daily or as directed by a physician. Children (2 years and older): Take half the adult dose.
Other information
Store in a cool dark place
Inactive ingredients
Active: As Above; Inactive: ENA 50% v/v and Purified Water q.s.
Questions?
QUESTIONS OR COMMENTS www.Rxhomeo.com | 1.888.2796642 | info@rxhomeo.com - Rxhomeo, Inc 2940 Eisenhower St., Suite 100, Carrollton, TX 75007 USA
Label text from the FDA structured product label by Rxhomeo Private Limited d.b.a. Rxhomeo, Inc (revised Jun 1, 2024). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Nitroglycerin in 19 products
Glonoinum NDC products (19)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 0220-2282 | Nitroglycerin 15 [hp_C]/15[hp_C] Pellet | Boiron | UNAPPROVED HOMEOPATHIC |
| 0220-2283 | Nitroglycerin 30 [hp_C]/30[hp_C] Pellet | Boiron | UNAPPROVED HOMEOPATHIC |
| 0220-2286 | Nitroglycerin 9 [hp_C]/9[hp_C] Pellet | Boiron | UNAPPROVED HOMEOPATHIC |
| 0220-2287 | Nitroglycerin 12 [hp_C]/12[hp_C] Pellet | Boiron | UNAPPROVED HOMEOPATHIC |
| 0220-2290 | Nitroglycerin 5 [hp_C]/5[hp_C] Pellet | Boiron | UNAPPROVED HOMEOPATHIC |
| 0220-2291 | Nitroglycerin 6 [hp_C]/6[hp_C] Pellet | Boiron | UNAPPROVED HOMEOPATHIC |
| 0220-2293 | Nitroglycerin 6 [hp_X]/1 Pellet | Boiron | UNAPPROVED HOMEOPATHIC |
| 0220-2279 | Nitroglycerin 200 [kp_C]/200[kp_C] Pellet | Boiron | UNAPPROVED HOMEOPATHIC |
| 37662-1655 | Nitroglycerin 1 [hp_Q]/1 Pellet | Hahnemann Laboratories, INC. | UNAPPROVED HOMEOPATHIC |
| 37662-1654 | Nitroglycerin 10 [hp_M]/1 Pellet | Hahnemann Laboratories, INC. | UNAPPROVED HOMEOPATHIC |
| 37662-1653 | Nitroglycerin 1 [hp_M]/1 Pellet | Hahnemann Laboratories, INC. | UNAPPROVED HOMEOPATHIC |
| 37662-1652 | Nitroglycerin 500 [hp_C]/1 Pellet | Hahnemann Laboratories, INC. | UNAPPROVED HOMEOPATHIC |
| 37662-1651 | Nitroglycerin 200 [hp_C]/1 Pellet | Hahnemann Laboratories, INC. | UNAPPROVED HOMEOPATHIC |
| 37662-1650 | Nitroglycerin 100 [hp_C]/1 Pellet | Hahnemann Laboratories, INC. | UNAPPROVED HOMEOPATHIC |
| 37662-1649 | Nitroglycerin 30 [hp_C]/1 Pellet | Hahnemann Laboratories, INC. | UNAPPROVED HOMEOPATHIC |
| 37662-1648 | Nitroglycerin 12 [hp_C]/1 Pellet | Hahnemann Laboratories, INC. | UNAPPROVED HOMEOPATHIC |
| 37662-1647 | Nitroglycerin 6 [hp_C]/1 Pellet | Hahnemann Laboratories, INC. | UNAPPROVED HOMEOPATHIC |
| 15631-2758 | Nitroglycerin 6 [hp_X]/mL Liquid | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | UNAPPROVED HOMEOPATHIC |
| 15631-0207 | Nitroglycerin 6 [hp_X]/1 Pellet | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | UNAPPROVED HOMEOPATHIC |
Frequently asked questions
What is Glonoinum used for?
Condition listed above or as directed by the physician
Who makes Glonoinum?
Glonoinum is listed by 3 labelers in the FDA NDC directory, including Boiron, Hahnemann Laboratories, INC., Rxhomeo Private Limited d.b.a. Rxhomeo, Inc.